RTO vs. NU, CPRT, PLTR, PAYX, WCN, FIS, SQ, VRSK, IT, and EFX
Should you be buying Rentokil Initial stock or one of its competitors? The main competitors of Rentokil Initial include NU (NU), Copart (CPRT), Palantir Technologies (PLTR), Paychex (PAYX), Waste Connections (WCN), Fidelity National Information Services (FIS), Block (SQ), Verisk Analytics (VRSK), Gartner (IT), and Equifax (EFX). These companies are all part of the "business services" sector.
NU (NYSE:NU) and Rentokil Initial (NYSE:RTO) are both large-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.
NU has a net margin of 13.86% compared to NU's net margin of 0.00%. Rentokil Initial's return on equity of 22.94% beat NU's return on equity.
In the previous week, NU had 6 more articles in the media than Rentokil Initial. MarketBeat recorded 11 mentions for NU and 5 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.31 beat NU's score of 1.13 indicating that NU is being referred to more favorably in the media.
80.9% of NU shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 1.2% of NU shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
NU currently has a consensus target price of $10.74, suggesting a potential downside of 9.69%. Rentokil Initial has a consensus target price of $29.00, suggesting a potential upside of 7.09%. Given NU's higher possible upside, analysts plainly believe Rentokil Initial is more favorable than NU.
NU received 24 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 53.06% of users gave NU an outperform vote while only 25.00% of users gave Rentokil Initial an outperform vote.
NU has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500.
NU pays an annual dividend of $1.67 per share and has a dividend yield of 14.0%. Rentokil Initial pays an annual dividend of $0.67 per share and has a dividend yield of 2.5%. NU pays out 642.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rentokil Initial has increased its dividend for 1 consecutive years.
NU has higher revenue and earnings than Rentokil Initial.
Summary
NU beats Rentokil Initial on 16 of the 19 factors compared between the two stocks.
Get Rentokil Initial News Delivered to You Automatically
Sign up to receive the latest news and ratings for RTO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rentokil Initial Competitors List
Related Companies and Tools
